Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

PI3K Activation in Neural Stem Cells Drives Tumorigenesis which can be Ameliorated by Targeting the cAMP Response Element Binding (CREB) Protein.

Daniel PM, Filiz G, Brown DV, Christie M, Waring PM, Zhang Y, Haynes JM, Pouton C, Flanagan D, Vincan E, Johns TG, Montgomery K, Phillips WA, Mantamadiotis T.

Neuro Oncol. 2018 Apr 30. doi: 10.1093/neuonc/noy068. [Epub ahead of print]

PMID:
29718345
2.

Optimizing Amplification of the GC-Rich TERT Promoter Region Using 7-Deaza-dGTP for Droplet Digital PCR Quantification of TERT Promoter Mutations.

Colebatch AJ, Witkowski T, Waring PM, McArthur GA, Wong SQ, Dobrovic A.

Clin Chem. 2018 Apr;64(4):745-747. doi: 10.1373/clinchem.2017.284257. Epub 2018 Jan 30. No abstract available.

PMID:
29382647
3.

An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practice.

Ellison G, Ahdesmäki M, Luke S, Waring PM, Wallace A, Wright R, Röthlisberger B, Ludin K, Merkelbach-Bruse S, Heydt C, Ligtenberg MJL, Mensenkamp AR, de Castro DG, Jones T, Vivancos A, Kondrashova O, Pauwels P, Weyn C, Hahnen E, Hauke J, Soong R, Lai Z, Dougherty B, Carr TH, Johnson J, Mills J, Barrett JC.

Hum Mutat. 2018 Mar;39(3):394-405. doi: 10.1002/humu.23375. Epub 2017 Dec 28.

4.

Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignancies.

Colebatch AJ, Di Stefano L, Wong SQ, Hannan RD, Waring PM, Dobrovic A, McArthur GA, Papenfuss AT.

Oncotarget. 2016 Oct 11;7(41):66569-66585. doi: 10.18632/oncotarget.11892.

5.

Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study.

Segelov E, Thavaneswaran S, Waring PM, Desai J, Robledo KP, Gebski VJ, Elez E, Nott LM, Karapetis CS, Lunke S, Chantrill LA, Pavlakis N, Khasraw M, Underhill C, Ciardiello F, Jefford M, Wasan H, Haydon A, Price TJ, van Hazel G, Wilson K, Simes J, Shapiro JD.

J Clin Oncol. 2016 Jul 1;34(19):2258-64. doi: 10.1200/JCO.2015.65.6843. Epub 2016 Apr 25.

PMID:
27114605
6.

High-Throughput Amplicon-Based Copy Number Detection of 11 Genes in Formalin-Fixed Paraffin-Embedded Ovarian Tumour Samples by MLPA-Seq.

Kondrashova O, Love CJ, Lunke S, Hsu AL; Australian Ovarian Cancer Study (AOCS) Group, Waring PM, Taylor GR.

PLoS One. 2015 Nov 16;10(11):e0143006. doi: 10.1371/journal.pone.0143006. eCollection 2015.

7.

AmpliVar: mutation detection in high-throughput sequence from amplicon-based libraries.

Hsu AL, Kondrashova O, Lunke S, Love CJ, Meldrum C, Marquis-Nicholson R, Corboy G, Pham K, Wakefield M, Waring PM, Taylor GR.

Hum Mutat. 2015 Apr;36(4):411-8. doi: 10.1002/humu.22763. Epub 2015 Mar 16.

PMID:
25664426
8.

Ubiquitous expression of the Pik3caH1047R mutation promotes hypoglycemia, hypoinsulinemia, and organomegaly.

Kinross KM, Montgomery KG, Mangiafico SP, Hare LM, Kleinschmidt M, Bywater MJ, Poulton IJ, Vrahnas C, Henneicke H, Malaterre J, Waring PM, Cullinane C, Sims NA, McArthur GA, Andrikopoulos S, Phillips WA.

FASEB J. 2015 Apr;29(4):1426-34. doi: 10.1096/fj.14-262782. Epub 2014 Dec 30.

PMID:
25550458
9.

Therapeutic inhibition of Jak activity inhibits progression of gastrointestinal tumors in mice.

Stuart E, Buchert M, Putoczki T, Thiem S, Farid R, Elzer J, Huszar D, Waring PM, Phesse TJ, Ernst M.

Mol Cancer Ther. 2014 Feb;13(2):468-74. doi: 10.1158/1535-7163.MCT-13-0583-T. Epub 2014 Jan 7.

10.

Physiological expression of the PI3K-activating mutation Pik3ca(H1047R) combines with Apc loss to promote development of invasive intestinal adenocarcinomas in mice.

Hare LM, Phesse TJ, Waring PM, Montgomery KG, Kinross KM, Mills K, Roh V, Heath JK, Ramsay RG, Ernst M, Phillips WA.

Biochem J. 2014 Mar 1;458(2):251-8. doi: 10.1042/BJ20131412.

PMID:
24320611
11.

Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.

Etemadmoghadam D, Au-Yeung G, Wall M, Mitchell C, Kansara M, Loehrer E, Batzios C, George J, Ftouni S, Weir BA, Carter S, Gresshoff I, Mileshkin L, Rischin D, Hahn WC, Waring PM, Getz G, Cullinane C, Campbell LJ, Bowtell DD.

Clin Cancer Res. 2013 Nov 1;19(21):5960-71. doi: 10.1158/1078-0432.CCR-13-1337. Epub 2013 Sep 4.

12.

Mutation detection by clonal sequencing of PCR amplicons and grouped read typing is applicable to clinical diagnostics.

Chambers PA, Stead LF, Morgan JE, Carr IM, Sutton KM, Watson CM, Crowe V, Dickinson H, Roberts P, Mulatero C, Seymour M, Markham AF, Waring PM, Quirke P, Taylor GR.

Hum Mutat. 2013 Jan;34(1):248-54. doi: 10.1002/humu.22207. Epub 2012 Oct 11.

PMID:
22915446
13.

Menin and p53 have non-synergistic effects on tumorigenesis in mice.

Loffler KA, Mould AW, Waring PM, Hayward NK, Kay GF.

BMC Cancer. 2012 Jun 18;12:252. doi: 10.1186/1471-2407-12-252.

14.

Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.

Samuel MS, Suzuki H, Buchert M, Putoczki TL, Tebbutt NC, Lundgren-May T, Christou A, Inglese M, Toyota M, Heath JK, Ward RL, Waring PM, Ernst M.

Gastroenterology. 2009 Sep;137(3):902-13, 913.e1-11. doi: 10.1053/j.gastro.2009.05.042. Epub 2009 May 18.

PMID:
19454286
15.

Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study.

Jenkins MA, Hayashi S, O'Shea AM, Burgart LJ, Smyrk TC, Shimizu D, Waring PM, Ruszkiewicz AR, Pollett AF, Redston M, Barker MA, Baron JA, Casey GR, Dowty JG, Giles GG, Limburg P, Newcomb P, Young JP, Walsh MD, Thibodeau SN, Lindor NM, Lemarchand L, Gallinger S, Haile RW, Potter JD, Hopper JL, Jass JR; Colon Cancer Family Registry.

Gastroenterology. 2007 Jul;133(1):48-56. Epub 2007 Apr 25.

16.

Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.

Loughrey MB, Waring PM, Tan A, Trivett M, Kovalenko S, Beshay V, Young MA, McArthur G, Boussioutas A, Dobrovic A.

Fam Cancer. 2007;6(3):301-10. Epub 2007 Apr 24.

PMID:
17453358
17.

Polyclonal resistance in gastrointestinal stromal tumor treated with sequential kinase inhibitors.

Loughrey MB, Waring PM, Dobrovic A, Demetri G, Kovalenko S, McArthur G.

Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6205-6; author reply 6206-7. No abstract available.

18.

Matching patients with drugs: triumphs and challenges.

Waring PM.

Per Med. 2006 Aug;3(3):335-344. doi: 10.2217/17410541.3.3.335.

PMID:
29788656
19.

Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clones.

Loughrey MB, Beshay V, Dobrovic A, Zalcberg J, Waring PM.

Histopathology. 2006 Jul;49(1):99-100. No abstract available.

PMID:
16842259
20.

KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.

Loughrey MB, Trivett M, Beshay V, Dobrovic A, Kovalenko S, Murray W, Lade S, Turner H, McArthur GA, Zalcberg J, Waring PM.

Histopathology. 2006 Jul;49(1):52-65.

PMID:
16842246
21.

Gastrointestinal stromal tumour treated with neoadjuvant imatinib.

Loughrey MB, Mitchell C, Mann GB, Michael M, Waring PM.

J Clin Pathol. 2005 Jul;58(7):779-81.

22.

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.

Tothill RW, Kowalczyk A, Rischin D, Bousioutas A, Haviv I, van Laar RK, Waring PM, Zalcberg J, Ward R, Biankin AV, Sutherland RL, Henshall SM, Fong K, Pollack JR, Bowtell DD, Holloway AJ.

Cancer Res. 2005 May 15;65(10):4031-40. Erratum in: Cancer Res. 2005 Sep 1;65(17):8057.

24.

Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group.

Reeves JH, Butt WW, Shann F, Layton JE, Stewart A, Waring PM, Presneill JJ.

Crit Care Med. 1999 Oct;27(10):2096-104.

PMID:
10548188
25.

Disruption of a homolog of trithorax by 11q23 translocations: leukemogenic and transcriptional implications.

Waring PM, Cleary ML.

Curr Top Microbiol Immunol. 1997;220:1-23. Review. No abstract available.

PMID:
9103672
26.

Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia.

Waring PM, Presneill J, Maher DW, Layton JE, Cebon J, Waring LJ, Metcalf D.

Clin Exp Immunol. 1995 Dec;102(3):501-6.

27.

Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice.

Waring PM, Waring LJ, Billington T, Metcalf D.

Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1337-41.

28.

Leukemia inhibitory factor: association with intraamniotic infection.

Waring PM, Romero R, Laham N, Gomez R, Rice GE.

Am J Obstet Gynecol. 1994 Nov;171(5):1335-41.

PMID:
7977543
29.

Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcemia.

Waring PM, Waring LJ, Metcalf D.

J Infect Dis. 1994 Nov;170(5):1224-8.

PMID:
7963717
30.

Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides.

Waring PM, Carroll GJ, Kandiah DA, Buirski G, Metcalf D.

Arthritis Rheum. 1993 Jul;36(7):911-5.

PMID:
8318039
31.

Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-alpha.

Hamilton JA, Waring PM, Filonzi EL.

J Immunol. 1993 Feb 15;150(4):1496-502.

PMID:
8432990
32.

Prostatic embryonal rhabdomyosarcoma in adults. A clinicopathologic review.

Waring PM, Newland RC.

Cancer. 1992 Feb 1;69(3):755-62. Review.

PMID:
1730126
33.

Clearance and fate of leukemia-inhibitory factor (LIF) after injection into mice.

Hilton DJ, Nicola NA, Waring PM, Metcalf D.

J Cell Physiol. 1991 Sep;148(3):430-9.

PMID:
1918172
34.

Rare earth deposits in a deceased movie projectionist. A new case of rare earth pneumoconiosis?

Waring PM, Watling RJ.

Med J Aust. 1990 Dec 3-17;153(11-12):726-30. Review.

PMID:
2247001
35.

Massive cutaneous tumour of the scalp. Sebaceous carcinoma.

Heenan PJ, Waring PM, Crocker AD.

Australas J Dermatol. 1990;31(2):115-6. No abstract available.

PMID:
2095735
36.

'Corkscrew-like' bacteria associated with gastritis.

Waring PM, Shilkin KB.

Histopathology. 1989 Dec;15(6):647-9.

PMID:
2606459
37.

Bladder granulomata after bladder surgery.

Spagnolo DV, Waring PM.

Am J Clin Pathol. 1986 Oct;86(4):430-7.

PMID:
3766458

Supplemental Content

Loading ...
Support Center